Share the post "Supriya Lifescience announced Financial Results Q1 2024"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 21.67 % in the past year, substantial increase in net sales/revenue by 1.55 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -23.78 %, Marginal increase in other income during this quarter, up by 1.78%.
- Profit over the Year and quarter: Significant improvement in profitability for Supriya Lifescience Limited. Notable increase of 56.57 % in net profit Year to Year, Supriya Lifescience Limited’s profitability increased by 20.88 % in this quarter.
- EPS over the Year and quarter: EPS increased by 56.50 % Year to Year. EPS increased by 20.7 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 132.021 Cr | Rs. 158.18 Cr | Rs. 160.626 Cr | + 1.55 % | + 21.67 % |
| Expenses | Rs. 87.53 Cr | Rs. 102.68 Cr | Rs. 98.08 Cr | -4.48 % | + 12.05 % |
| Operating Profit | Rs. 44.49 Cr | Rs. 55.5 Cr | Rs. 62.55 Cr | + 12.7 % | + 40.59 % |
| OPM % | 33.7 % | 35.09 % | 38.94 % | + 3.85 % | + 5.24 % |
| Other Income | Rs. 2.918 Cr | Rs. 2.185 Cr | Rs. 2.224 Cr | + 1.78 % | -23.78 % |
| Interest | Rs. 0.82 Cr | Rs. 0.6 Cr | Rs. 0.34 Cr | -43.33 % | -58.54 % |
| Depreciation | Rs. 3.96 Cr | Rs. 3.91 Cr | Rs. 4.66 Cr | + 19.18 % | + 17.68 % |
| Profit before tax | Rs. 42.63 Cr | Rs. 53.18 Cr | Rs. 59.77 Cr | + 12.39 % | + 40.21 % |
| Tax % | 33.13 % | 30.55 % | 25.31 % | -5.24 % | -7.82 % |
| Net Profit | Rs. 28.51 Cr | Rs. 36.93 Cr | Rs. 44.64 Cr | + 20.88 % | + 56.58 % |
| EPS in Rs | Rs. 3.54 | Rs. 4.59 | Rs. 5.54 | + 20.7 % | + 56.5 % |
Today, we’re looking at Supriya Lifescience Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 21.67 %. However, it did see a marginal increase of 1.55 % from the previous quarter. Expenses decreased slightly by -4.48 % quarter-on-quarter, aligning with the annual rise of 12.05 %. Operating profit, while up 40.59 % compared to last year, faced a quarter-on-quarter increase of 12.7 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 5.24 %, but an expansion of 3.85 % sequentially. Other income rose by 1.78 % compared to the last quarter, despite an annual decline of -23.78 %. Interest expenses dropped significantly by -43.33 % from the previous quarter, yet the year-over-year decrease remains at a moderate -58.54 %. Depreciation costs climbed by 19.18 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 17.68 %. Profit before tax grew annually by 40.21 % but saw an increase from the preceding quarter by 12.39 %.
Tax expenses as a percentage of profits decreased slightly by -7.82 % compared to last year, with a more notable quarter-on-quarter decrease of -5.24 %. Net profit rose by 56.58 % year-on-year but experienced a 20.88 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 56.5 % but a quarterly rise of 20.7 %. In summary, Supriya Lifescience Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 132.021 Cr | Rs. 158.18 Cr | Rs. 160.626 Cr | + 1.55 % | + 21.67 % |
| Expenses | Rs. 87.53 Cr | Rs. 102.68 Cr | Rs. 98.08 Cr | -4.48 % | + 12.05 % |
| Operating Profit | Rs. 44.49 Cr | Rs. 55.5 Cr | Rs. 62.55 Cr | + 12.7 % | + 40.59 % |
| Net Profit | Rs. 28.51 Cr | Rs. 36.93 Cr | Rs. 44.64 Cr | + 20.88 % | + 56.58 % |
| EPS in Rs | Rs. 3.54 | Rs. 4.59 | Rs. 5.54 | + 20.7 % | + 56.5 % |
In reviewing Supriya Lifescience Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 21.67 % year-on-year growth, however, there was a minor increase of 1.55 % from the previous quarter. Expenses rose by 12.05 % compared to the previous year, with a decrease of -4.48 % quarter-on-quarter. Operating Profit surged by 40.59 % annually, and saw a 12.7 % increase from the last quarter.
Net Profit showed yearly increase of 56.58 %, and experienced a 20.88 % increase from the previous quarter. Earnings Per Share (EPS) rose by 56.5 % annually, however rose by 20.7 % compared to the last quarter. In essence, while Supriya Lifescience Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”Supriya Lifescience “]
